Cargando…
The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447629/ https://www.ncbi.nlm.nih.gov/pubmed/32843656 http://dx.doi.org/10.1038/s41392-020-00283-8 |